Concepedia

Karen S. Hartl

KS

16

Publications

701

Citations

15

H-Index

1990

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Karen S. Hartl is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1990–2019

16

Publications

16

Development of Potent Thrombin Receptor Antagonist Peptides

Michael S. Bernatowicz, Clifford E. Klimas, Karen S. Hartl et al. · Journal of Medicinal Chemistry · 1996 · 145 citations · Full text

, , +15

Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats

William A. Schumacher, Steven E. Seiler, Thomas E. Steinbacher et al. · European Journal of Pharmacology · 2007 · 86 citations

, , +10

Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors

James Sutton, Scott A. Bolton, Karen S. Hartl et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 67 citations · Full text

, , +5

Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors

James Sutton, Scott A. Bolton, Malcolm E. Davis et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 63 citations · Full text

, , +5

Synthesis of potent and highly selective inhibitors of human tryptase

William A. Slusarchyk, Scott A. Bolton, Karen S. Hartl et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 49 citations · Full text

, , +9

Rows per page

1–5 of 16